ELEANOR ROOSEVELT INSTITUTE FOR CA… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1960

Legal Domicile

Principal Officer

DAVID PATTERSON

Phone

3038715650

Tax Period

2021-07-01 to 2022-06-30

ELEANOR ROOSEVELT INSTITUTE FOR CANCER RESEARCH, founded in 1960, is a micro nonprofit that reported $37K in total revenue in fiscal year 2021. Revenue fell 35% from the prior year — a significant decline worth monitoring. Expenses of $45K exceeded revenue, resulting in a 22% operating deficit.

Mission

RAISE FUNDS FOR BIOMEDICAL RESEARCH

Program Service Accomplishments

Program 1

Expenses: $44,854 Revenue: $0

THE ELEANOR ROOSEVELT INSTITUTE FOR CANCER RESEARCH'S ONLY PROGRAM SERVICE IS BASIC RESEARCH IN HUMAN GENETIC DISEASES. ALL RESEARCH REVENUE AND EXPENSE ARE FOR THIS PURPOSE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2021)

Revenue Breakdown

Contributions & Grants $10,700

Program Service Revenue $0

Investment Income $26,154

Other Revenue $0

TOTAL REVENUE $36,854

Expense Breakdown

Grants Paid $44,854

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $44,854

Other Expenses $0

TOTAL EXPENSES $44,854

Year-over-Year Comparison

	2021	2020	Change
Revenue	$36,854	$56,503	-0.3%
Expenses	$44,854	$56,128	-0.2%
Net Income	$-8,000	$375	-22.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DAVID PATTERSON PHD	PRESIDENT AND CHAIRPERSON	5	Officer Director	$0	$0	$0
LOTTA GRANHOLM-BENTLEY PHD	TRUSTEE	0.3	Director	$0	$0	$0
ANDREI KUTATELADZE	TRUSTEE	0.3	Director	$0	$0	$0
FORD ROOSEVELT	TRUSTEE	0.3	Director	$0	$0	$0
LYNN TAUSSIG MD	TRUSTEE	0.3	Director	$0	$0	$0
DANIEL LINSEMAN PHD	VICE PRESIDENT	2	Officer	$0	$0	$0
BRIONY CATLOW PHD	SECRETARY	0.5	Officer	$0	$0	$0
JOEL BENSON	SECRETARY-TREASURER	0.3	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$36,854	$44,854	$483,489	$-8,000
2021	$56,503	$56,128	$595,228	$375

ELEANOR ROOSEVELT INSTITUTE FOR CANCER RESEARCH